NCT01443806View on ClinicalTrials.gov

Characterisation of the Human Carboxylesterase 1 (CES1) Mutations in Thailand

PHASE4CompletedINTERVENTIONAL
Enrollment

1

Participants

Timeline

Start Date

July 31, 2011

Primary Completion Date

December 31, 2012

Study Completion Date

December 31, 2012

Conditions
Metabolic Disease
Interventions
DRUG

Oseltamivir

75 mg, one time

Trial Locations (1)

10400

The Faculty of Tropical medicine,Mahidol University, Bangkok

All Listed Sponsors
collaborator

South East Asia Infectious Disease Clinical Research Network

NETWORK

lead

University of Oxford

OTHER

NCT01443806 - Characterisation of the Human Carboxylesterase 1 (CES1) Mutations in Thailand | Biotech Hunter | Biotech Hunter